DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD

QR Code

DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD

A new method for determination of moxifloxacin in human plasma using HPLC with UV-detection is described. The sample preparation was made by protein precipitation by 50% trifluoracetic acid solution. The method was validated in terms of selectivity, calibration curve, accuracy, precision, lower limi...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. N. Komarov, Yu. V. Medvedev, I. E. Shohin, Yu. E. Boldina, A. A. Lvova, E. S. Melnikov, E. N. Fisher, R. V. Ivanov, R. J. Maksvitis
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	moxifloxacin plasma hplc-uv
Online Access:	https://www.pharmjournal.ru/jour/article/view/307
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR MOXIFLOXACINE TABLETS
by: L. A. Menshikova, et al.
Published: (2019-01-01)

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
by: T. N. Komarov, et al.
Published: (2022-09-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method
by: T. N. Komarov, et al.
Published: (2020-05-01)

Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV
by: P. A. Karpova, et al.
Published: (2022-05-01)

Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
by: D. S. Bogdanova, et al.
Published: (2019-05-01)

Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method
by: T. N. Komarov, et al.
Published: (2020-02-01)

HPLC-MS/MS method development and validation for the determination of tetradecapeptide in human plasma
by: M. A. Tokareva, et al.
Published: (2024-06-01)

The determination of topiramate in plasma rabbit blood by HPLC with specific derivatization
by: G. V. Ramenskaya, et al.
Published: (2011-09-01)

Comparison of the Efficacy of Moxifloxacin Preparations in the Therapy of Conjunctivitis
by: A. Yu. Malygin, et al.
Published: (2025-06-01)

Development, Validation and Approbation Analytical Method for the Quantitative Determination of Taurine by HPLC-UV Method in the Test of Comparative Dissolution Kinetics
by: A. M. Poluyanov, et al.
Published: (2023-05-01)

Validation of the HPLC-UV Method for Quantitative Determination of Steroid Sapogenin Diosgenin from Hay Fenugreek Seeds, Trigonella Foenum-graecum L.
by: A. E. Sukhanov, et al.
Published: (2020-11-01)

Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2020-11-01)

Recent HPLC-UV Approaches for Cannabinoid Analysis: From Extraction to Method Validation and Quantification Compliance
by: Eduarda M. P. Silva, et al.
Published: (2025-05-01)

Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method
by: A. V. Aleshina, et al.
Published: (2021-05-01)

Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS
by: P. K. Karnakova, et al.
Published: (2021-11-01)

Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2019-11-01)

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-05-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS
by: A. A. Lvova, et al.
Published: (2019-01-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2021-02-01)

Development and Validation of an HPLC-MS/MS Method for the Quantitative Determination of Etmaben in Human Blood Plasma
by: P. K. Karnakova, et al.
Published: (2024-03-01)

Validation of a HPLC-UV analytical and bioanalytical method for dexamethasone determination in nanoemulsions, porcine nasal mucosa, and mouse plasma and brain tissue
by: Luísa Degrandi Sehn, et al.
Published: (2025-07-01)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-09-01)

Engineering Moxifloxacin-Encapsulated Liposome-Enriched Alginate Hydrogel Films
by: Ismail Bal, et al.
Published: (2025-06-01)

Simultaneous stability-indicating analysis of nateglinide and pioglitazone using RP-HPLC
by: Sriparni Das, et al.
Published: (2025-12-01)

Development and validation of the quantification of GIZH-298, possessing in the rat blood plasma by HPLC-UF
by: O. G. Gribakina, et al.
Published: (2019-02-01)

The simultaneous determination of lycopene and β-carotene in fruit vegetables and plasma by HPLC
by: LI Xiang-rong, et al.
Published: (2000-07-01)

Efficacy of Levofloxacin, Lomefloxacin and Moxifloxacin vs. Other Fluoroquinolones in Experimental Plague Due to FI+ and FI<sup>-</sup> Strains of Yersiniapestis in Albino Mice
by: I. V. Ryzhko, et al.
Published: (2020-05-01)

Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres
by: ZeWen Qiao, et al.
Published: (2019-12-01)

Development and Validation of Eltrombopag Determination in Human Plasma Blood by HPLC-MS Method
by: А. М. AL-Dhuraibi, et al.
Published: (2022-11-01)

Development and validation of the methods for determination of tenophovir in the blood plasma of rabbits
by: Yu. V. Medvedev, et al.
Published: (2011-09-01)

HPLC method for simultaneous determination of oxytocin and clorobutanol in injectable solutions
by: Luciana Paraschiv, et al.
Published: (2013-11-01)

Large‐Scale Analysis of Age and Sex Effects on Corrected QT and JT Intervals: Insights From Hospital‐Based Controls and Moxifloxacin‐Treated Cases
by: Eunwoo Kim, et al.
Published: (2025-06-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19
by: Ikhwan Rinaldi, et al.
Published: (2020-08-01)

The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19
by: Ikhwan Rinaldi, et al.
Published: (2020-08-01)

DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)
by: A. A. Lvova, et al.
Published: (2019-01-01)

Evaluation of Glycyrrhizic Acid Content in Licorice Roots and Products of its Processing by HPLC-UV Method
by: B. V. Brovchenko, et al.
Published: (2019-05-01)

Development and validation of a RP-HPLC method for the quantisation studies of metronidazole and furazolidone from product Enteroguard M
by: Elena Gabriela Oltean,, et al.
Published: (2010-12-01)

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-02-01)

HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements
by: I. E. Shohin, et al.
Published: (2021-05-01)